FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

37421311000001105: Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
336821000001110 Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
336841000001117 Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet Has AMP Reltebon 40mg modified-release tablets (CST Pharma Ltd) true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet Is a Oxycodone 40mg modified-release tablets 56 tablet true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start